Usefulness of a New Parameter in Functional Assessment in Patients With Idiopathic Pulmonary Fibrosis: Desaturation- Distance Ratio From the Six-Minute Walk Test

dc.contributor.author Aktan, Ridvan
dc.contributor.author Tertemiz, Kemal Can
dc.contributor.author it, Salih Yi
dc.contributor.author Özalevli, Sevgi
dc.contributor.author Özgen Alpaydın, Aylın
dc.contributor.author Uçan, Eyüp Sabri
dc.date.accessioned 2023-09-11T17:53:41Z
dc.date.available 2023-09-11T17:53:41Z
dc.date.issued 2023
dc.description.abstract Background and aim: New parameters in the 6-minute walk test (6MWT) are needed for assessing exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). To our knowledge, no previous study has investigated the potential of using the desaturation distance ratio (DDR) to assess exercise capacity specifically in patients with IPF. This study aimed to investigate whether DDR is a potential tool for assessing the exercise capacity of patients with IPF. Methods: This study conducted with 33 subjects with IPF. Pulmonary function tests and a 6MWT were performed. To calculate the DDR, first, the difference between the patient's SpO(2) at each minute and the SpO(2) of 100% was summed together to determine the desaturation area (DA). Next, DDR was calculated using dividing DA by the 6-minute walk test distance (6MWD) (i.e., DA/6MWD). Results: When correlations of 6MWD and DDR with changes (.) in the severity of perceived dyspnea were examined, 6MWD did not significantly correlate with Borg. Conversely, there was a significant correlation between the DDR and Borg (r= 0.488, p=0.004). There were significant correlations between 6MWD and FVC % (r=0.370, p=0.034), and FEV1 % (r=0.465, p=0.006). However, DDR was significantly more correlated with FVC % (r= -0.621, p< 0.001), FEV1 % (r= -0.648, p< 0.001). Moreover, there was a significant correlation between DDR and DLCO % (r= -0.342, p=0.052). Conclusions: The findings of this study suggest that DDR is a promising and more useful parameter for assessing patients with IPF. en_US
dc.identifier.doi 10.36141/svdld.v40i2.14634
dc.identifier.issn 1124-0490
dc.identifier.issn 2532-179X
dc.identifier.scopus 2-s2.0-85164351227
dc.identifier.uri https://doi.org/10.36141/svdld.v40i2.14634
dc.identifier.uri https://hdl.handle.net/20.500.14365/4793
dc.language.iso en en_US
dc.publisher Mattioli 1885 en_US
dc.relation.ispartof Sarcoidosis Vasculitis And Diffuse Lung Diseases en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Idiopathic pulmonary fibrosis en_US
dc.subject Six-minute walk en_US
dc.subject Exercise en_US
dc.subject Desaturation en_US
dc.subject Desaturation distance ratio en_US
dc.subject EXERCISE CAPACITY en_US
dc.subject PROGNOSTIC VALUE en_US
dc.subject STANDARDIZATION en_US
dc.title Usefulness of a New Parameter in Functional Assessment in Patients With Idiopathic Pulmonary Fibrosis: Desaturation- Distance Ratio From the Six-Minute Walk Test en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Aktan, Ridvan/0000-0002-3327-461X
gdc.author.institutional
gdc.author.scopusid 57203551117
gdc.author.scopusid 14026151600
gdc.author.scopusid 57222814812
gdc.author.scopusid 21743831700
gdc.author.scopusid 36020072500
gdc.author.scopusid 6602113638
gdc.author.wosid Aktan, Ridvan/Q-8888-2016
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department İzmir Ekonomi Üniversitesi en_US
gdc.description.departmenttemp [Aktan, Ridvan] Izmir Univ Econ, Dept Physiotherapy, Izmir, Turkiye; [Tertemiz, Kemal Can; it, Salih Yi; Alpaydin, Aylin Ozgen; Ucan, Eyup Sabri] Dokuz Eylul Univ, Fac Med, Dept Chest Dis, Izmir, Turkiye; [Ozalevli, Sevgi] Dokuz Eylul Univ, Fac Phys Therapy & Rehabil, Izmir, Turkiye; [Aktan, Ridvan] Izmir Univ Econ, Vocat Sch Hlth Serv, Sakarya St 156, TR-35330 Izmir, Turkiye en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q4
gdc.description.volume 40 en_US
gdc.description.wosquality Q3
gdc.identifier.pmid 37382067
gdc.identifier.wos WOS:001023568800011
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.4895952E-9
gdc.oaire.isgreen true
gdc.oaire.keywords Original Article: Clinical Research
gdc.oaire.popularity 2.0536601E-9
gdc.oaire.publicfunded false
gdc.opencitations.count 0
gdc.plumx.facebookshareslikecount 1849
gdc.plumx.mendeley 7
gdc.plumx.pubmedcites 1
gdc.plumx.scopuscites 3
gdc.scopus.citedcount 3
gdc.virtual.author Aktan, Rıdvan
gdc.wos.citedcount 3
relation.isAuthorOfPublication d632f46b-1e0b-42cb-ae90-5b5d7abaf0fd
relation.isAuthorOfPublication.latestForDiscovery d632f46b-1e0b-42cb-ae90-5b5d7abaf0fd
relation.isOrgUnitOfPublication 9ab3ca4c-b851-47d8-9a41-5cbe1b60457e
relation.isOrgUnitOfPublication 102d99a4-5f52-4392-af31-1ecf89cc7516
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery 9ab3ca4c-b851-47d8-9a41-5cbe1b60457e

Files